Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 52% ± 27% | |
astrocyte | 8 studies | 39% ± 21% | |
oligodendrocyte precursor cell | 8 studies | 31% ± 13% | |
GABAergic neuron | 7 studies | 53% ± 27% | |
cardiac muscle cell | 5 studies | 42% ± 11% | |
interneuron | 4 studies | 61% ± 29% | |
neuron | 3 studies | 26% ± 2% | |
endothelial cell | 3 studies | 28% ± 10% | |
GABAergic interneuron | 3 studies | 29% ± 10% | |
retinal ganglion cell | 3 studies | 28% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1000.74 | 258 / 258 | 90% | 11.67 | 207 / 230 |
pancreas | 99% | 600.95 | 325 / 328 | 79% | 2.65 | 140 / 178 |
brain | 85% | 909.91 | 2246 / 2642 | 87% | 6.19 | 611 / 705 |
prostate | 95% | 772.65 | 233 / 245 | 75% | 2.81 | 377 / 502 |
thymus | 95% | 487.74 | 620 / 653 | 72% | 2.15 | 436 / 605 |
liver | 87% | 359.23 | 196 / 226 | 63% | 1.97 | 256 / 406 |
kidney | 90% | 350.03 | 80 / 89 | 57% | 3.31 | 513 / 901 |
stomach | 97% | 780.99 | 350 / 359 | 40% | 1.57 | 113 / 286 |
intestine | 98% | 766.33 | 942 / 966 | 31% | 0.99 | 164 / 527 |
esophagus | 63% | 776.28 | 913 / 1445 | 50% | 2.35 | 91 / 183 |
lung | 66% | 228.22 | 380 / 578 | 43% | 1.48 | 499 / 1155 |
uterus | 79% | 311.54 | 135 / 170 | 26% | 1.23 | 120 / 459 |
muscle | 100% | 6498.34 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 3107.72 | 823 / 861 | 0% | 0 | 0 / 0 |
bladder | 71% | 670.62 | 15 / 21 | 23% | 0.64 | 114 / 504 |
blood vessel | 89% | 558.41 | 1192 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 2.60 | 51 / 80 |
ovary | 41% | 119.11 | 73 / 180 | 19% | 0.44 | 83 / 430 |
spleen | 54% | 185.15 | 131 / 241 | 0% | 0 | 0 / 0 |
breast | 15% | 48.12 | 68 / 459 | 36% | 1.89 | 397 / 1118 |
skin | 0% | 2.14 | 7 / 1809 | 40% | 1.59 | 188 / 472 |
adipose | 20% | 59.10 | 240 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 12% | 86.93 | 110 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.28 | 3 / 29 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.21 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0031982 | Cellular component | vesicle |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005229 | Molecular function | intracellularly calcium-gated chloride channel activity |
GO_0005254 | Molecular function | chloride channel activity |
Gene name | ANO5 |
Protein name | Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) Anoctamin Anoctamin 5 |
Synonyms | GDD1 TMEM16E |
Description | FUNCTION: Plays a role in plasma membrane repair in a process involving annexins . Does not exhibit calcium-activated chloride channel (CaCC) activity. . |
Accessions | ENST00000683411.1 ENST00000682341.1 ENST00000682530.1 ENST00000683437.1 ENST00000683197.1 A0A804HL91 ENST00000684663.1 ENST00000682266.1 A0A346A6F2 A0A804HHX6 ENST00000324559.9 A0A804HLK6 A0A804HJT6 A0A804HKP2 Q75V66 |